Abstract
Biodegradability and adhesive-associated local drug release are important aspects of research in tissue adhesive development. Therefore, this study focuses on investigating the in vitro degradation and drug release of a tissue adhesive consisting of hexamethylene diisocyanate functionalized 1,2-ethylene glycol bis(dilactic acid) and chitosan chloride. To prevent infections, ciprofloxacin hydrochloride (CPX·HCl) was incorporated into the adhesive. The influence of CPX·HCl on the adhesive reaction and adhesive strength was analyzed by FTIR-ATR-spectroscopy and tensile tests. The CPX·HCl release was investigated by HPLC. The degradation-induced changes at 37 °C were evaluated by gravimetric/morphological analyzes and micro-computer tomography. The antibiotic potential of the CPX·HCl loaded adhesive was determined by agar diffusion tests. The degradation tests revealed a mass loss of about 78 % after 52 weeks. The adhesive reaction velocity and tensile strength were not influenced by CPX·HCl. Using a 2 mg/g CPX·HCl loaded adhesive an inhibition of all tested bacteria was observed.
Similar content being viewed by others
References
Ryou M, Thompson Ch. Tissue adhesives: a review. Tech Gastrointest Endosc. 2006;8(1):33–7.
Seewald S, Sriram PV, Naga M, Fennerty MB, Boyer J, Oberti F, Soehendra N. Cyanoacrylate glue in gastric variceal bleeding. Endoscopy. 2002;34(11):926–32.
Chivers RA, Wolowacz RG. The strength of adhesive-bonded tissue joints. Int J Adhes. 1997;17:127–32.
Leggat PA, Smith DR, Kedjarune U. Surgical applications of cyanoacrylate adhesives: a review of toxicity. ANZ J Surg. 2007;77(4):209–13.
Tseng YC, Tabata Y, Hyon SH, Ikada Y. In vitro toxicity test of 2-cyanoacrylate polymers by cell culture method. J Biomed Mater Res. 1990;24(10):1355–67.
Toriumi DM, Rasian WF, Friedman M, Tardy ME. Histotoxicity of cyanoacrylate tissue adhesives: a comparative study. Arch Otolaryngol Head Neck Surg. 1990;116(5):546–50.
Papatheofonis FJ. Cytotoxicity of alkyl-2-cyanoacrylate adhesives. J Biomed Mater Res. 1989;23(6):661–8.
Dunn CJ, Goa KL. Fibrin sealant: a review of its use in surgery and endoscopy. Drugs. 1999;58(5):863–86.
Flahiff C, Feldman D, Saltz R, Huang S. Mechanical properties of fibrin adhesives for blood vessel anastomosis. J Biomed Mater Res. 1992;26(4):481–91.
Sierra DH, Feldmann DS, Saltz R, Huang S. A method to determine shear adhesive strength of fibrin sealants. J Appl Biomater. 1992;3:147–51.
Weber SC, Chapman MW. Adhesives in orthopaedic surgery. a review of the literature and in vitro bonding strengths of bone-bonding agents. Clin Orthop Relat Res. 1984;191:249–61.
Heiss C, Kraus R, Schluckebier D, Stiller AC, Wenisch S, Schnettler R. Bone adhesives in trauma and orthopedic surgery. Eur J Trauma Emerg Surg. 2006;32(2):141–8.
Ferreira P, Silva AFM, Pinto MI, Gil MH. Development of a biodegradable bioadhesive containing urethane groups. J Mater Sci Mater Med. 2008;19(1):111–20.
Ferreira P, Pereira R, Coelho JFJ, Silva AFM, Gil MH. Modification of the biopolymer castor oil with free isocyanate groups to be applied as bioadhesive. Int J Biol Macromol. 2007;40(2):144–52.
Sheikh N, Mirzadeh H, Katbab AA, Salehian P, Daliri M, Amanpour S. Isocyanate-terminated urethane prepolymer as bioadhesive material: evaluation of bioadhesion and biocompatibility, in vitro and in vivo assays. J Biomater Sci Polymer Edn. 2001;12(7):707–19.
Sung HW, Huang DM, Chang WH, Huang RN, Hsu JC. Evaluation of gelatin hydrogel crosslinked with various crosslinking agents as bioadhesives: in vitro study. J Biomed Mater Res. 1999;46(4):520–30.
Chao HH, Torchiana DF. BioGlue: albumin/glutaraldehyde sealant in cardiac surgery. J Card Surg. 2003;18(6):500–3.
Tatehata H, Mochizuki A, Ohkawa K, Yamada M, Yamamoto H. Tissue adhesive using synthetic model adhesive proteins inspired by the marine mussel. J Adhes Sci Technol. 2001;15:1003–13.
Hwang DS, Gim Y, Yoo HJ, Cha HJ. Practical recombinant hybrid mussel bioadhesive fp-151. Biomaterials. 2007;28(24):3560–8.
Schnabelrauch M, Vogt S, Larcher Y, Wilke I. Biodegradable polymer networks based on oligolactide macromers: synthesis, properties and biomedical applications. Biomol Eng. 2002;19(2–6):295–8.
Vogt S, Larcher Y, Beer B, Wilke I, Schnabelrauch M. Fabrication of highly porous scaffold materials based on functionalized oligolactides and preliminary results on their use in bone tissue engineering. Eur Cell Mater. 2002;4:30–8.
Sternberg K, Rohm HW, Lurtz C, Wegmann J, Odermatt EK, Behrend D, Michalik D, Schmitz KP. Development of a biodegradable tissue adhesive based on functionalized 1,2-ethylene glycol bis(dilactic acid). I. J Biomed Mater Res B. 2010;94(2):318–26.
Ulubayram K, Aksu E, Gurhan SI, Serbetci K, Hasirci N. Cytotoxicity evaluation of gelatin sponges prepared with different cross-linking agents. J Biomater Sci Polym Ed. 2002;13(11):1203–19.
Kim J, Kim IS, Cho TH, Lee KB, Hwang SJ, Tae G, Noh I, Lee SH, Park Y, Sun K. Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials. 2007;28(10):1830–7.
Bhaskara Rao S, Sharma CP. Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential. J Biomed Mater Res. 1997;34:21–8.
Salgado AJ, Coutinho OP, Reis RL, Davies JE. In vivo response to starch-based scaffolds designed for bone tissue engineering applications. J Biomed Mater Res A. 2007;80(4):983–9.
Lim SM, Song DK, Oh SH, Lee-Yoon DS, Bae EH, Lee JH. In vitro und in vivo degradation behaviour of acetylated chitosan porous beads. J Biomater Sci Polym Ed. 2008;19(4):453–66.
Rohm H, Lurtz C, Wegmann J, Odermatt E, Behrend D, Schmitz KP, Sternberg K. Development of a biodegradable tissue adhesive based on functionalized 1,2-ethylene glycol bis(dilactic acid). Part II. J Biomed Mater Res B. 2011;97(1):66–73.
Freier T, Koha HS, Kazaziana K, Shoichet MS. Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials. 2005;26:5872–8.
Hankiewicz J, Swierczek E. Lysozyme in human body fluids. Clin Chim Acta. 1974;57:205–9.
Vårum KM, Myhr MM, Hjerde RJ, Smidsrød O. In vitro degradation rates of partially N-acetylated chitosans in human serum. Carbohydr Res. 1997;299(1–2):99–101.
Yu BG, Kwon IC, Kim YH, Han DK, Park KD, Han K, Jeong SY. Development of a local antibiotic delivery system using fibrin glue. J Control Release. 1996;39:65–70.
Zilch H, Labiris E. The sustained release of cefotaxime from a fibrin-cefotaxime compound in treatment of osteitis. Arch Orthop Trauma Surg. 1986;106:36–41.
Kram HB, Bansal M, Timberlake O, Shoemaker WC. Antibacterial effects of fibrin glue-antibiotic mixtures. J Surg Res. 1991;50:175–8.
Tompson DF, Davis TW. The addition of antibiotics to fibrin glue. South Med J. 1997;90(7):681–4.
Heiss C, Hahn N, Wenisch S, Alt V, Pokinskyj P, Horas U, Kilian O, Schnettler R. The tissue response to an alkylene bis(dilactoyl)-methacrylate bone adhesive. Biomaterials. 2005;26(12):1389–96.
International Organization of Standardization (ISO). 15814: Implants for surgery-copolymers and blends based on polylactide—in vitro degradation testing. 1999.
Heiss C, Hahn N, Pokinskyj P, Wenisch S, Stahl JP, Meyer CH, Schnettler R. Properties and degradation of a new bioresorbable bone glue. Biomed Technik. 2004;49:163–9.
Brouwer J, van Leeuwen-Herberts T, Otting-van de Ruit M. Determination of lysozyme in serum, urine, cerebrospinal fluid and feces by enzyme immunoassay. Clin Chim Acta. 1984;142:21–30.
Porstmann B, Jung K, Schmechta H, Evers U, Pergande M, Porstmann T, Kramm HJ, Krause H. Measurement of lysozyme in human body fluids: comparison of various enzyme immunoassay techniques and their diagnostic application. Clin Biochem. 1989;22:349–55.
Tomihata K, Ikada Y. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials. 1997;16:567–75.
Onishi H, Machida Y. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials. 1999;20:175–82.
Aktories K, Förstermann U, Hofmann FB, Starke K. Allgemeine und spezielle pharmakologie und toxikologie. 10th ed. München: Elsevier GmbH, Urban & Fischer Verlag; 2009. p. 1076.
Radosevich M, Goubran HI, Burnouf T. Fibrin sealant: scientific rationale, production methods, properties, and current clinical use. Vox Sang. 1997;72(3):133–43.
Mintz PD, Mayers L, Avery N, Flanagan HL, Burks SG, Spotnitz WD. Fibrin sealant: clinical use and the development of the University of Virginia Tissue Adhesive Center. Ann Clin Lab Sci. 2001;31(1):108–18.
Lee M-GM, Jones D. Applications of fibrin sealant in surgery. Surg Innov. 2005;12:203–13.
Muzzarelli RAA, Mattioli-Belmonte M, Miliani M, Muzzarelli C, Gabbanelli F, Biagini G. In vivo and in vitro biodegradation of oxychitin–chitosan and oxypullulan–chitosan complexes. Carbohydr Polym. 2002;48(1):15–21.
Gorzelanny C, Pöppelmann B, Pappelbaum K, Moerschbacher BM, Schneider SW. Human macrophage activation triggered by chitotriosidase-mediated chitin and chitosan degradation. Biomaterials. 2010;31(33):8556–63.
Mori T, Murakami M, Okumura M, Kadosawa T, Uede T, Fujinaga T. Mechanism of macrophage activation by chitin derivatives. J Vet Med Sci. 2005;67(1):51–6.
Spicer PP, Mikos AG. Fibrin glue as a drug delivery system. J Control Release. 2010;148(1):49–55.
European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of IICs and zone diameters—Version 1.3. 2011.
Acknowledgments
The authors would like to thank Martina Schröder and Jaqueline Bohm for their expert technical assistance as well as Dr. Thomas Reske for his helpful support in chromatographic analyzes. Furthermore, Prof. Dr. Gerhard Hennighausen and Thilo Storm are gratefully acknowledged for their helpful notes and suggestions. The work was financially supported by Bundesministerium für Bildung und Forschung (BMBF) within the REMEDIS project “Höhere Lebensqualität durch neuartige Mikroimplantate” (FKZ: 03IS2081).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lurtz, C., Voss, K., Hahn, V. et al. In vitro degradation and drug release of a biodegradable tissue adhesive based on functionalized 1,2-ethylene glycol bis(dilactic acid) and chitosan. J Mater Sci: Mater Med 24, 667–678 (2013). https://doi.org/10.1007/s10856-012-4826-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10856-012-4826-9